Cervical human papillomavirus infection in Tunisian women

Infection

Volumn 31, Issue 3, 2003, Pages 143-148

  Hassen, E ^a   Chaieb, A ^b   Letaief, M ^a   Khairi, H ^b   Zakhama, A ^a   Remadi, S ^c   Chouchane, L ^a  

^a Medicine Faculty   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

^c Laboratoire Cytopath   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

RESTRICTION ENDONUCLEASE; VIRUS DNA;

ADULT; ARTICLE; CANCER RISK; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; DNA DETERMINATION; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 6; INFECTION RISK; MAJOR CLINICAL STUDY; MARRIAGE; MOLECULAR TYPING; ONCOGENE; POLYMERASE CHAIN REACTION; PREVALENCE; PROSTITUTION; RESTRICTION MAPPING; RISK FACTOR; SEXUAL INTERCOURSE; TUNISIA; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0038792353     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3112-7     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Munoz N, Ferlay J: Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400.
2. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version I.O. IARC Cancer Base No. 5. Lyon, IARC Press, 2001. Limited version available from: URL:http://www-dep.iarc.fr/globocan/globocan.htm. Last updated on 03/02/2001.
3. IARC: IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 64. Lyon: International agency for research on cancer, 1995.
4. Kiviat NB, Koutsky LA, Paavonen JA, Galloway DA, Critchlow CW, Beckmann AM, McDougall JK, Marcia L, Peterson ML, Stevens CE, Lipinski CM, Holmes KK: Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Inf Dis 1989; 159: 293-302.
5. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM: Genital Human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472-477.
6. Munoz N: Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-5.
7. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, Tarmo MJ, Moreo P, Ascunce N, Gonzalez JC: Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750-758.
8. Chaouki N, Bosh FX, Munoz N, Meijer CJ, EI Gueddari B, EI Ghazi A, Deacon J, Castellsague X, WaIboomers JMM: The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 1998; 75: 546-555.
9. Khan JA, Rosenthal SL, Succop PA, Ho GYF, Burk RD: Mediators of the association between age at first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 2002; 109: 1-8.
10. Reeves WC, Gary HE, Johnson PR, Icenogle JP, Brenes MM, de Britton RM, Dobbins JG, Schmid DS: Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer. J Inf Dis 1994; 170: 753-758.
11. Kjaer SK, Engholm G, Teisen C, Haugaard BJ, Lynge E, Christensen RB, Moller KA, Jensen H, Poll P, Vestergaard BF, De Villiers EM, Jensen OM: Risk factors for cervical human papillomavirus and herpes simplex virus infection in Greenland and Denmark: a population-based study. Am J Epidemiol 1990; 131: 669-682.
12. Rolon PA, Smith JS, Munoz N, Klug SJ, Herrero R, Bosch X, Llamoras F, Meijer CJ, Walboomers JMM: Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 2000; 85: 486-491.
13. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N: Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
14. Ting Y, Monas MM: Detection and typing of genital human papillomavirus. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): PCR protocols: a guide to methods and applications. San Diego, Academic Press, 199, pp 356-367.
15. Fujinaga Y, Shimada M, Okazawa K, Fukushima M, Kato I, Fuginaga K: Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 1991; 72: 1039-1044.
16. Jenison SA, Yu XP, Valentine JM, Koutsky LA, Christiansen AE, Beckmann AM, Galloway DA: Evidence of prevalent genital type human papillomavirus infections in adults and children. J Inf Dis 1990; 162: 60-69.
17. Tham KM, Chow VTK, Singh P, Tock EP, Ching KC, Lim-Tan SK, Sng IT, Bernard HU: Diagnostic sensitivity of polymerase chain reaction and southern blot hybridisation for the detection of human papillomavirus DNA in biopsy specimens from cervical lesions. Am J Clin Pathol 1991; 95: 638-646.
18. Anceschi MM, Falcinelli C, Pieretti M, Cosmi EV: Multiple primer pairs polymerase chain reaction for the detection of human papillomavirus types. J Virol Methods 1990; 28: 59-66.
19. Ter Meulen J, Eberhardt HC, Luand J, Mgaya HN, Chang-Claude J, Mtiro H, Mhina M, P Kashaija P, Ockert S, Yu X, Meinhardt G, Gissman L, Pawlita M: Human papillomavirus infection, HIV and infection and cervical cancer in Tanzania, East Africa. Int J Cancer 1992; 51: 515-521.
20. Marais DJ, Vardas E, Ramjee G, Allan B, Kay P, Rose RC, Willianson AL: The impact of human immunodifiency type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. J Infect Dis 2000; 182: 1239-1242.
21. Shanta V, Krishnamutthi S, Gajalaskshmi CK, Swaminathan R, Ravichandran K: Epidemiology of cancer of the cervix: global and national perspective. J Indian Med Assoc 2000; 98: 49-52.
22. Drain PK, Holmes KK, Hughes JP, Koutsky LA: Determinants of cervical cancer rates in developing countries. Int J Cancer 2002; 100: 199-205.
23. Melkert PWJ, Hopman E, Van Den Brule AJC, Risse EK, Van Diest PJ, Bleker OP, Helmerhorst I, Schipper ME, Meijer CJ, Walboomers JMM: Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age dependant. Int J Cancer 1993; 53: 919-923.
24. Kiviat N: Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996; 175: 1099-1104.
25. Koutsky LA, Gallowway DA, Homles KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163.
26. Kjaer SK, Svare EI, Worm AM, Walboomers JMM, Meijer CJLM, Van Den Brule AJC: Human papillomavirus infection in Danish female sex workers, decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000; 27: 438-445.
27. Veress G, Konya J, Csiky-Meszaros T, Czegledy J, Gergely L: Human papillomavirus DNA anti-HPV secretory IgA antibodies in cytologically normal cervical specimens. J Med Virol 1994; 43: 201-207.
28. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R: Sexual behaviour and partners characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Inf Dis 1996; 174: 679-689.
29. Hankins C, Coutlee F, Lapointe N, Simard P, Samson J, Hum L: Prevalence of risk factors associated papillomavirus infection in women living with HIV. Can Med Assoc J 1999; 160: 185-191.
30. Rousseau MC, Franco EL, Villa LL, Sobrinko JP, Termini L, Prado JM, Rohan TE: A cumulative case-control study of risk factor profiles for oncogenic and non-oncogenic cervical human papillomavirus infections. Cancer Epidemiol Biomarkers Prev 2000; 9: 469-476.